Why is "III/IV" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-07-20 18:09:54
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
III/IV entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-07-20 and was most recently seen on 2026-07-20.
Wikipedia Overview
III/IV is the twelfth studio album by alt-country singer-songwriter Ryan Adams, released on December 14, 2010 through PAX AM. The album is his fifth with backing band The Cardinals, and was recorded in 2006 during the same sessions that yielded Easy Tiger. A double album, III/IV was recorded prior to bassist Catherine Popper's departure, and also marks guitarist and backing vocalist Neal Casal's recording debut for the band. According to Adams, the album remained unreleased until 2010, as his former label, Lost Highway, had previously rejected it.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
ART MATTERS: On the moral good — Part III of IV - The Daily Gazette
-
Nivolumab Sustains 9-Year Survival Benefit in Resected Stage III/IV Melanoma - CancerNetwork
-
The role of group III/IV afferent feedback in the ventilatory, pressor and metabolic responses to exercise in normoxia and hypoxia - Wiley & Sons
-
Anne Vilsbøll - Artnet
-
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial - Nature
-
U.S. Banking Agencies Propose Sweeping Overhaul of Capital Framework - Part II: Category III and IV Banking Organizations - Jones Day
-
NASA Seeks Interest for Artemis Mission CubeSats - NASA (.gov)
-
Mike Dickson Honored as the ABCA/ATEC NCAA Division III Region IV Coach of the Year - Rowan University Athletics
-
FDA Approves Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma - OncLive
-
Schedule 1, 2, 3, 4 & 5 Drugs: Controlled Substance Classifications - MedShadow Foundation
-
US Banking Regulators Propose Reforms to Capital Requirements - Mayer Brown
-
NASA and contractors accelerate mobile launcher refurbishment, Artemis III hardware to meet new schedule - Aerospace America
-
Grey Zabel & Kenneth Walker III Active, Ernest Jones IV Inactive For Seahawks' Week 12 Game at Tennessee - Seattle Seahawks
-
Latham & Watkins Advises Terra-Gen on US$383.3 Million Project Financing for Lockhart III & IV Solar Project - Latham & Watkins LLP
-
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting - Yahoo Finance
-
GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting - PR Newswire
-
U.S. Banking Agencies Propose Sweeping Overhaul of Capital Framework - Part IV: Foreign Banking Organizations - Jones Day
-
Discriminability of selected periods III‒IV elements in photon-counting computed tomography using a pixelated CdTe detector - Nature
-
NASA Strengthens Artemis: Adds Mission, Refines Overall Architecture - NASA (.gov)
-
Enantioselective difluoromethylation of unactivated alkyl halides via a formal nickel(II/IV) cycle - Nature
-
Adjuvant Nivolumab/Relatlimab Shows No Added Benefit in Resected Melanoma - Targeted Oncology
-
NASA Adds Mission to Artemis Lunar Program, Updates Architecture - NASA (.gov)
-
Davis Cup Regionals Return - Davis Cup - The World Cup of Tennis - daviscup.com
-
NJAC Places 21 on NFCA Division III All-Region IV Teams - New Jersey Athletic Conference
-
HS TRACK AND FIELD: 2026 Lackawanna Track Conference Division III-IV Honor Roll (FINAL) - Scranton Times-Tribune
-
A novel AI-powered radiographic analysis surpasses specialists in stage II–IV periodontitis detection: a multicenter diagnostic study - Nature
-
Circumferential Negative Pressure Lymphedema Therapy: A Novel Rapid Perioperative Decongestion Strategy for Advanced Stage III-IV Lymphedema - Cureus
-
From GAP III to GAP IV: Rethinking the EU’s global support for gender equality - ODI: Think change
-
BOYS TRACK AND FIELD: 2026 Lackawanna Track Conference Coaches’ Division III-IV All-Stars - Scranton Times-Tribune
-
Clear Aligner Therapy in Adults With Stage II-IV Periodontitis: A Narrative Review - Cureus
-
Davis Cup Group IV Preview - Davis Cup - The World Cup of Tennis - daviscup.com
-
HS TRACK AND FIELD: 2026 Lackawanna Track Conference Division III-IV Honor Roll (Week 2) - Scranton Times-Tribune
-
NASA has revealed what the Artemis III mission will look like – and says crew could be announced soon - BBC Sky at Night Magazine
-
HS TRACK AND FIELD: 2026 Lackawanna Track Conference Division III-IV Honor Roll (Week 5) - Scranton Times-Tribune
-
Major Changes to NASA’s Artemis III and Artemis IV Missions to the Moon - Discover Magazine
-
Multicancer Early Detection Test Fails to Reduce Cancers Detected at Late Stages - MedPage Today
-
NASA announces major overhaul of Artemis moon program amid safety concerns, delays: "We've got to get back to basics" - CBS News
-
Soldiers receive and prepare Class III and Class IV for distribution to maneuver units before 3rd MBCT’s JRTC Rotation - DVIDS
-
mRNA Vaccine/Pembrolizumab Shows Sustained 5-Year RFS in High-Risk Melanoma - CancerNetwork
-
HS TRACK AND FIELD: 2026 Lackawanna Track Conference Division III-IV Honor Roll (Week 4) - Scranton Times-Tribune
-
GIRLS TRACK AND FIELD: 2026 Lackawanna Track Conference Coaches’ Division III-IV All-Stars - Scranton Times-Tribune
-
Terra-Gen Announces Closing of Project Financing for Lockhart III & IV Solar Project - Business Wire
-
HS TRACK AND FIELD: 2026 Lackawanna Track Conference Division III-IV Honor Roll (Week 3) - Scranton Times-Tribune
-
What is NASA’s Artemis II moon mission, and when will it launch? - Al Jazeera
-
Division III & IV Track and Field Championships 5/8/26 - PinalCentral.com
-
Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses - Clinical Lab Products
-
Who will win girls lacrosse titles this spring? We've got the answers. - The Providence Journal
-
Sony a7S III & a7 IV firmware updates - Newsshooter
-
Artemis III will practice docking while Musk’s Starship and Bezos’ Blue Moon compete for Artemis IV - Fortune
-
SC vs IV Toripalimab in Advanced nsqNSCLC: A Phase III Trial - Oncodaily
-
Looking ahead to NASA’s Artemis III, IV and V missions - Yahoo
-
Rural Patients Face Higher Risk of Late-Stage Breast Cancer, Especially When Uninsured - The American Journal of Managed Care
-
Davis Cup 2026 calendar dates - Davis Cup - The World Cup of Tennis - daviscup.com
-
Looking ahead to NASA's Artemis III, IV and V missions - NewsNation
-
SWOG S1826 3-year follow-up: N-AVD vs BV-AVD in adolescents with AS cHL - Lymphoma Hub
-
Artemis III to be Earth orbit mission, Artemis IV moon mission - Laredo Morning Times
-
There's plenty of talent in D-III and IV boys lacrosse. Here's proof. - The Providence Journal
-
HS TRACK AND FIELD: 2026 LTC Division III-IV Honor Roll (Week 1) - Scranton Times-Tribune
-
Lenovo Leads the Circular IT Shift with a New Chapter to Extend Lifecycles for Aging Tech - Lenovo StoryHub
-
2026 AIA Arizona Wrestling State Championship Schedule And Brackets - FloWrestling
-
Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melano - Yahoo Finance
-
Fenwick girls, CCD's Luke Schneiber lead way at Division III, IV indoor state track meet - Cincinnati Enquirer
-
Dose-dense paclitaxel and novel combination maintenance therapies offer survival benefits in advanced ovarian cancer - ESMO Daily Reporter
-
Head and neck cancers: should research continue to invest in immunotherapy? - ESMO Daily Reporter
-
Total Hip Arthroplasty for Crowe III/IV Hip Dysplasia With Oblique Subtrochanteric Shortening Osteotomy and S-ROM-A Modular Stem: 10-Year Outcomes - Wiley Online Library
-
Pope John Paul II High School Cross Country Sweeps Titles at Westside Classic District II IV Championship - ThurstonTalk
-
Terra-Gen closes financing for 205MW Lockhart III & IV solar project in California - PV Tech
-
Where Thomas Booker IV fits on Raiders’ 3-4 defensive front - Silver And Black Pride
-
Antibiotic Prophylaxis in Infants with Grade III, IV, or V Vesicoureteral Reflux - The New England Journal of Medicine
-
Asia/Oceania Group IV preview - daviscup.com
-
Shell Makes $16.4 Billion Bet on Montney - JPT Homepage
-
Group IV preview - daviscup.com
-
The OLGIMA system for gastric cancer risk assessment. A useful method based on the histological Sydney consensus - Wiley Online Library
-
Are all drugs judged equally? What is drug scheduling in the US and how do Schedule I, II, III, IV and V differ? - WION
-
Missile mass production to commence in Q2: official - Taipei Times
-
Clinical Outcomes of Patients With Bethesda III or IV Cytology on Fine Needle Aspiration of Thyroid Nodules—A Retrospective Study - Khan - 2025 - Endocrinology, Diabetes & Metabolism - Wiley Online Library
-
Prime Minister Muhammad Shehbaz Sharif inaugurates Sky47, Pakistan’s first purpose-built, AI-ready Tier III/IV data center and sovereign cloud platform. - | Associated Press Of Pakistan
-
IHN01 Trial: Adjuvant CRT remains standard as nimotuzumab fails to lift DFS/OS in resected stage III/IV HNSCC - Oncodaily
-
Trampled Under Foot" 1975 UK Promo single will be released on 7" vinyl for RSD Black Friday. - Led Zeppelin | Official Website
-
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma - The New England Journal of Medicine
-
Golf III/IV Cabriolet (1993–2002) - Volkswagen Newsroom
-
2026 Wrestling Big Ten Tourney: Session III Recap & Session IV Preview - Black Shoe Diaries
-
MassLive releases 2025 All-Western Mass. Football selections for Divisions I, III, IV, V, VI, VII & VIII - MassLive
-
Riverwalk Phase III & IV: $131.1M bridge financing secured for luxury multifamily in Elmwood Park - JLL
-
Structure and function of the S. pombe III–IV–cyt c supercomplex - PNAS
-
Engine versions Golf III/IV Cabriolet profile - Volkswagen Newsroom
-
Ricoh GR III vs GR IV: I Dismissed It Until I Shot With It - The Cotswold Photographer
-
Nivolumab + Relatlimab Fails to Improve RFS in Resectable Stage III/IV Melanoma in Phase 3 RELATIVITY-098 Trial - ASCO Daily News
-
Control of hyperpnoea and pulmonary gas exchange during prolonged exercise: The role of group III/IV muscle afferent feedback - Wiley & Sons
-
Structural basis of mitochondrial membrane bending by the I–II–III2–IV2 supercomplex - Nature
-
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma - The New England Journal of Medicine
-
Blood test to detect 50 types of cancer fails to meet key outcome in NHS trial - Pulse Today
-
Adjuvant Nivolumab Plus Relatlimab Misses the Mark in Resected Stage III to IV Melanoma - OncLive
-
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma - The New England Journal of Medicine
-
Cartel Damages Without Economic Experts? The Implications of the German Federal Supreme Court Decisions Trucks III & IV - Wolters Kluwer
-
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma - The New England Journal of Medicine
-
Comparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer - Wiley & Sons
-
Delhi AQI soars to 455: GRAP stage III-IV triggers vehicle curbs, 50% WFH for offices, hybrid classes for - The Times of India
-
2025 Division Power Ranking Winners Revealed by ORA - Multifamily Executive
-
Rcf2 revealed in cryo-EM structures of hypoxic isoforms of mature mitochondrial III-IV supercomplexes - PNAS
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.